A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase

Nitric Oxide - Biology and Chemistry

Volumn 12, Issue 2, 2005, Pages 97-104

  Wallerath, Thomas ^a   Li, Huige ^a   Gödtel Ambrust, Ute ^a   Schwarz, Petra M ^a   Förstermann, Ulrich ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cardiovascular disease; Endothelial nitric oxide synthase; Polyphenols; Red wine

Indexed keywords

ANTHOCYANIN; BENZOIC ACID; CAFFEIC ACID; CATECHIN; COUMARIC ACID; CYANIDIN 3 GLUCOSIDE; DELPHINIDIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPICATECHIN; FERULIC ACID; FISETIN; FLAVANOL DERIVATIVE; FLAVONOL DERIVATIVE; GALLIC ACID; HYPERIN; ISOQUERCITRIN; MALVIDIN CHLORIDE; MYRICETIN; PAEONIDIN; PARA COUMARIC ACID; POLYPHENOL DERIVATIVE; RESVERATROL; SINAPIC ACID; UNCLASSIFIED DRUG; VANILLIC ACID;

ARTICLE; CARDIOVASCULAR DISEASE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTECTION; PROTEIN EXPRESSION; RED WINE; UPREGULATION;

EID: 14644405529     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2004.12.004     Document Type: Article

References (42)

1. M. Gronbaek, and T.I. Sorensen Alcohol consumption and risk of coronary heart disease. Studies suggest that wine has additional effect to that of ethanol Br. Med. J. 313 1996 365
2. M. Gronbaek, A. Deis, T.I. Sorensen, U. Becker, P. Schnohr, and G. Jensen Mortality associated with moderate intakes of wine, beer, or spirits Br. Med. J. 310 1995 1165 1169
3. A.S. St Leger, A.L. Cochrane, and F. Moore Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine Lancet 1 1979 1017 1020
4. J.B. German, and R.L. Walzem The health benefits of wine Annu. Rev. Nutr. 20 2000 561 593
5. R.D. Langer, M.H. Criqui, and D.M. Reed Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease Circulation 85 1992 910 915
6. E.B. Rimm, A. Klatsky, D. Grobbee, and M.J. Stampfer Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits Br. Med. J. 312 1996 731 736
7. M.J. Halpern, A.L. Dahlgren, I. Laakso, T. Seppanen-Laakso, J. Dahlgren, and P.A. McAnulty Red-wine polyphenols and inhibition of platelet aggregation: possible mechanisms, and potential use in health promotion and disease prevention J. Int. Med. Res. 26 1998 171 180
8. A.A. de Lorimier Alcohol, wine, and health Am. J. Surg. 180 2000 357 361
9. G. de Gaetano, and C. Cerletti Wine and cardiovascular disease Nutr. Metab. Cardiovasc. Dis. 11 2001 47 50
10. E. Andriambeloson, C. Magnier, G. Haan-Archipoff, A. Lobstein, R. Anton, A. Beretz, J.C. Stoclet, and R. Andriantsitohaina Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta J. Nutr. 128 1998 2324 2333
11. M. Flesch, A. Schwarz, and M. Bohm Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries Am. J. Physiol. 275 1998 H1183 H1190
12. T. Wallerath, D. Poleo, H. Li, and U. Förstermann Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects J. Am. Coll Cardiol. 41 2003 471 478
13. T. Wallerath, G. Deckert, T. Ternes, H. Anderson, H. Li, K. Witte, and U. Förstermann Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase Circulation 106 2002 1652 1658
14. H. Li, S.A. Oehrlein, T. Wallerath, I. Ihrig-Biedert, P. Wohlfart, T. Ulshöfer, T. Jessen, T. Herget, U. Förstermann, and H. Kleinert Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene Mol. Pharmacol. 53 1998 630 637
15. T. Wallerath, K. Witte, S.C. Schafer, P.M. Schwarz, W. Prellwitz, P. Wohlfart, H. Kleinert, H.A. Lehr, B. Lemmer, and U. Förstermann Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension Proc. Natl. Acad. Sci. USA 96 1999 13357 13362
16. A.Y. Borovkov, and M.I. Rivkin XcmI-containing vector for direct cloning of PCR products Biotechniques 22 1997 812 814
17. G. Mojzisova, and M. Kuchta Dietary flavonoids and risk of coronary heart disease Physiol. Res. 50 2001 529 535
18. M.B. Cishek, M.T. Galloway, M. Karim, J.B. German, and C.T. Kappagoda Effect of red wine on endothelium-dependent relaxation in rabbits Clin. Sci. (Lond.) 93 1997 507 511
19. E. Andriambeloson, A.L. Kleschyov, B. Muller, A. Beretz, J.C. Stoclet, and R. Andriantsitohaina Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta Br. J. Pharmacol. 120 1997 1053 1058
20. E. Andriambeloson, J.C. Stoclet, and R. Andriantsitohaina Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta J. Cardiovasc. Pharmacol. 33 1999 248 254
21. U. Alheid, J.C. Frölich, and U. Förstermann Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets Thromb. Res. 47 1987 561 571
22. M.W. Radomski, R.M. Palmer, and S. Moncada The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium Biochem. Biophys. Res. Commun. 148 1987 1482 1489
23. A.M. Zeiher, B. Fisslthaler, B. Schray Utz, and R. Busse Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells Circ. Res. 76 1995 980 986
24. P. Kubes, M. Suzuki, and D.N. Granger Nitric oxide: an endogenous modulator of leukocyte adhesion Proc. Natl. Acad. Sci. USA 88 1991 4651 4655
25. K.L. Davenpeck, T.W. Gauthier, and A.M. Lefer Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation Gastroenterology 107 1994 1050 1058
26. R. De Caterina, P. Libby, H.B. Peng, V.J. Thannickal, T.B. Rajavashisth, M.A. Gimbrone Jr., W.S. Shin, and J.K. Liao Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines J. Clin. Invest. 96 1995 60 68
27. T.W. Gauthier, R. Scalia, T. Murohara, J.P. Guo, and A.M. Lefer Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 15 1995 1652 1659
28. R. Draijer, D.E. Atsma, A. van der Laarse, and V.W. van Hinsbergh cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells Circ. Res. 76 1995 199 208
29. 2+-induced LDL oxidation by nitric oxide: a study using donors with different half-time of NO release Biochem. Biophys. Res. Commun. 220 1996 306 309
30. T. Nakaki, M. Nakayama, and R. Kato Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells Eur. J. Pharmacol. 189 1990 347 353
31. U.C. Garg, and A. Hassid Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells J. Clin. Invest. 83 1989 1774 1777
32. R.K. Dubey, E.K. Jackson, and T.F. Lüscher Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors J. Clin. Invest. 96 1995 141 149
33. H. Li, and U. Förstermann Nitric oxide in the pathogenesis of vascular disease J. Pathol. 190 2000 244 254
34. H. Li, T. Wallerath, T. Münzel, and U. Förstermann Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs Nitric Oxide 7 2002 149 164
35. R. Ratnasabapathy In vitro characterization of an estrogen-regulated mRNA stabilizing activity in the avian liver Cell Mol. Biol. Res. 41 1995 583 594
36. W.N. Ratna, and J.A. Simonelli The action of dietary phytochemicals quercetin, catechin, resveratrol and naringenin on estrogen-mediated gene expression Life Sci. 70 2002 1577 1589
37. S. Benito, D. Lopez, M.P. Saiz, S. Buxaderas, J. Sanchez, P. Puig-Parellada, and M.T. Mitjavila A flavonoid-rich diet increases nitric oxide production in rat aorta Br. J. Pharmacol. 135 2002 910 916
38. U. Förstermann, U. Alheid, J.C. Frölich, and A. Mülsch Mechanisms of action of lipoxygenase and cytochrome P-450-mono-oxygenase inhibitors in blocking endothelium-dependent vasodilatation Br. J. Pharmacol. 93 1988 569 578
39. M. Chiesi, and R. Schwaller Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin Biochem. Pharmacol. 49 1995 495 501
40. U. Hink, H. Li, H. Mollnau, M. Oelze, E. Matheis, M. Hartmann, M. Skatchkov, F. Thaiss, R.A.K. Stahl, A. Warnholtz, T. Meinertz, K. Griendling, D.G. Harrison, U. Förstermann, and T. Münzel Mechanisms underlying endothelial dysfunction in diabetes mellitus Circ.Res. 88 2001 E14 E22
41. T. Münzel, H. Li, H. Mollnau, U. Hink, E. Matheis, M. Hartmann, M. Oelze, M. Skatchkov, A. Warnholtz, L. Duncker, T. Meinertz, and U. Förstermann Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability Circ. Res. 86 2000 E7 E12
42. H. Mollnau, M. Wendt, K. Szocs, B. Lassegue, E. Schulz, M. Oelze, H. Li, M. Bodenschatz, M. August, A.L. Kleschyov, N. Tsilimingas, U. Walter, U. Förstermann, T. Meinertz, K. Griendling, and T. Munzel Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling Circ. Res. 90 2002 E58 E65